Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | MTMR4 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | VMP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | ATOX1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | ZNF48 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | LRRC37A2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | SYT11 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | AGO3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | MAST3 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | PALM | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |